Pacific Biosciences of California, Inc. (PACB) Capital expenditures 2016–2025
Pacific Biosciences of California, Inc. (PACB) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$2.7MFY2025 · since FY2016: $8.2M → $2.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.7M | -56.1% |
| FY2024 | $6.2M | -30.0% |
| FY2023 | $8.8M | -47.2% |
| FY2022 | $16.8M | +182.4% |
| FY2021 | $5.9M | +470.8% |
| FY2020 | $1.0M | -63.4% |
| FY2019 | $2.8M | +53.0% |
| FY2018 | $1.9M | -82.2% |
| FY2017 | $10.4M | +27.1% |
| FY2016 | $8.2M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice